[Lung cancer screening with low dose CT requires careful consideration]

Ugeskr Laeger. 2014 Oct 13;176(42):V06140341.
[Article in Danish]


Results from the American National Lung Screening Trial (NLST) show a significant reduction in lung cancer and all-cause mortality in a high risk population screened with annual low-dose CT. Handling of pulmonary nodules, false positive tests, overdiagnosis, psychosocial consequences and cost-efficiency etc. are all aspects that require careful consideration. This paper gives an overview of the current knowledge on these issues. Before a recommendation can be made, we need an overall evaluation of both the benefits and harms in CT screening for lung cancer.

Publication types

  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Diagnostic Errors
  • Early Detection of Cancer
  • False Positive Reactions
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / diagnostic imaging*
  • Mass Screening* / economics
  • Mass Screening* / psychology
  • Mass Screening* / standards
  • Radiation Dosage
  • Risk Factors
  • Smoking / psychology
  • Tomography, X-Ray Computed / methods